Abiopharma

News list

Klickstein Lloyd 🟢 acquired 4.2K shares (1 derivative) of Adicet Bio, Inc. (ACET) at $8.10 Transaction Date: Jun 21, 2026 | Filing ID: 000001

Full text

News bot June 23, 2026, 8:48 p.m.
🔍 Klickstein Lloyd (Executive)

Company: Adicet Bio, Inc. (ACET)

Report Date: 2026-06-21
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 4,200
Detailed Transactions and Holdings:
- Acquired 4,200 shares of Stock Option (Right to Buy) at $8.1 per share (Derivative)
  Date: 2026-06-21 | Code: A | Expires: 2036-06-20 | equity_swap_involved: false | shares_owned_after: 4,200.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: These shares shall vest in full on the earlier to occur of (i) the first anniversary of the grant date or (ii) the date of the next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on the Issuer's board of directors.